In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19

• Príomhchruthaitheoirí: Andrés López-Cortés (Údar), Patricia Guevara-Ramírez (Údar), Nikolaos C. Kyriakidis (Údar), Carlos Barba-Ostria (Údar), Ángela León Cáceres (Údar), Santiago Guerrero (Údar), Esteban Ortiz-Prado (Údar), Cristian R. Munteanu (Údar), Eduardo Tejera (Údar), Doménica Cevallos-Robalino (Údar), Ana María Gómez-Jaramillo (Údar), Katherine Simbaña-Rivera (Údar), Adriana Granizo-Martínez (Údar), Gabriela Pérez-M (Údar), Silvana Moreno (Údar), Jennyfer M. García-Cárdenas (Údar), Ana Karina Zambrano (Údar), Yunierkis Pérez-Castillo (Údar), Alejandro Cabrera-Andrade (Údar), Lourdes Puig San Andrés (Údar), Carolina Proaño-Castro (Údar), Jhommara Bautista (Údar), Andreina Quevedo (Údar), Nelson Varela (Údar), Luis Abel Quiñones (Údar), César Paz- (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Frontiers Media S.A., 2021-02-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Background: There is pressing urgency to identify therapeutic targets and drugs that allow treating COVID-19 patients effectively.Methods: We performed in silico analyses of immune system protein interactome network, single-cell RNA sequencing of human tissues, and artificial neural networks to reve...